CLINICAL TRIALS PROFILE FOR QUALAQUIN
✉ Email this page to a colleague
All Clinical Trials for QUALAQUIN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00785486 ↗ | Drug-Drug Interaction Study of Qualaquin and Midazolam | Completed | Mutual Pharmaceutical Company, Inc. | Phase 1 | 2007-03-01 | This is an open label non-randomized single sequence, single group two way drug interaction study in healthy adult volunteers to determine the extent to which quinine, an inducer of cytochrome p450 CYP 3A4, affects the pharmacokinetics of midazolam, an accepted probe drug for CYP 3A4. The study will also determine the extent to which midazolam affects the pharmacokinetics of quinine. |
| NCT00785551 ↗ | Comparative Study of Quinine Sulfate in Healthy Patients and in Patients With Renal Impairment | Terminated | Mutual Pharmaceutical Company, Inc. | Phase 1 | 2007-11-01 | The effects of mild or moderate renal impairment (creatinine clearance 30 to 50 ml/min or >50 to 80 ml/min, respectively) on the pharmacokinetic profile of quinine and its active metabolite, 3'-hydroxyquinine, will be investigated. Safety and tolerability in healthy subjects versus those with mild to moderate renal impairment will be compared, as well. |
| NCT00806078 ↗ | Comparison Bioavailability Study of Quinine Sulfate in Chocolate Pudding | Completed | Mutual Pharmaceutical Company, Inc. | Phase 1 | 2007-07-01 | This is an open label randomized single dose two-way crossover study to compare the bioavailability of a single oral dose of quinine sulfate 648 mg(2 x 324 mg) when mixed with 120 ml of chocolate pudding relative to the same dose given as two intact capsules. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for QUALAQUIN
Condition Name
Clinical Trial Locations for QUALAQUIN
Trials by Country
Clinical Trial Progress for QUALAQUIN
Clinical Trial Phase
Clinical Trial Sponsors for QUALAQUIN
Sponsor Name
